Kelli A Cole1, Kaitlyn R Rivard2, Lisa E Dumkow3. 1. Department of Pharmacy Services, University of Toledo Medical Center, 3000 Arlington Ave. MS 1013, Toledo, OH, 43614, USA. kelli.cole@utoledo.edu. 2. Department of Pharmacy, Cleveland Clinic, 9500 Euclid Avenue (Hb-105), Cleveland, OH, 44195, USA. 3. Department of Pharmacy Services, Mercy Health Saint Mary's, 200 Jefferson SE, Grand Rapids, MI, 49503, USA. Lisa.dumkow@mercyhealth.com.
Abstract
PURPOSE OF REVIEW: Overutilization of antimicrobials is a known contributor to the development of antimicrobial resistance, which is a threat to global health. The goal of antimicrobial stewardship programs (ASPs) is to implement targeted interventions to reduce inappropriate antimicrobial prescribing and prevent development of antimicrobial resistance. We aim to review recently published literature focused on five categories of ASP interventions that have demonstrated success in optimizing appropriate antimicrobial use, improving patient outcomes, and fighting antimicrobial resistance. RECENT FINDINGS: In the past year, ASP interventions in the published literature have focused on minimizing duration of antimicrobial therapy for infectious syndromes, implementing novel methods for performing prospective audit and feedback, utilizing microbiology laboratory or rapid diagnostic tests to expedite diagnosis, leveraging clinical decision support and electronic medical record tools, and performing penicillin allergy assessment. While the majority of studies assessing ASP interventions do not assess changes in antimicrobial resistance, outcomes demonstrating improved appropriate antibiotic use have been used as a surrogate. Successful ASPs should seek to implement and evaluate novel interventions targeting improvement in antimicrobial prescribing. Such interventions are of critical importance to prevent further growth of antimicrobial resistance.
PURPOSE OF REVIEW: Overutilization of antimicrobials is a known contributor to the development of antimicrobial resistance, which is a threat to global health. The goal of antimicrobial stewardship programs (ASPs) is to implement targeted interventions to reduce inappropriate antimicrobial prescribing and prevent development of antimicrobial resistance. We aim to review recently published literature focused on five categories of ASP interventions that have demonstrated success in optimizing appropriate antimicrobial use, improving patient outcomes, and fighting antimicrobial resistance. RECENT FINDINGS: In the past year, ASP interventions in the published literature have focused on minimizing duration of antimicrobial therapy for infectious syndromes, implementing novel methods for performing prospective audit and feedback, utilizing microbiology laboratory or rapid diagnostic tests to expedite diagnosis, leveraging clinical decision support and electronic medical record tools, and performing penicillin allergy assessment. While the majority of studies assessing ASP interventions do not assess changes in antimicrobial resistance, outcomes demonstrating improved appropriate antibiotic use have been used as a surrogate. Successful ASPs should seek to implement and evaluate novel interventions targeting improvement in antimicrobial prescribing. Such interventions are of critical importance to prevent further growth of antimicrobial resistance.
Authors: Besu F Teshome; Scott Martin Vouri; Nicholas Hampton; Marin H Kollef; Scott T Micek Journal: Pharmacotherapy Date: 2019-01-07 Impact factor: 4.705
Authors: Kimberly G Blumenthal; Erin E Ryan; Yu Li; Hang Lee; James L Kuhlen; Erica S Shenoy Journal: Clin Infect Dis Date: 2018-01-18 Impact factor: 9.079
Authors: Sarah Dunaway; Kara W Orwig; Zachary Q Arbogast; Zachary L Myers; James A Sizemore; Stephanie E Giancola Journal: Int J Clin Pharm Date: 2018-05-02
Authors: Ralph Gonzales; Tammy Anderer; Charles E McCulloch; Judith H Maselli; Frederick J Bloom; Thomas R Graf; Melissa Stahl; Michelle Yefko; Julie Molecavage; Joshua P Metlay Journal: JAMA Intern Med Date: 2013-02-25 Impact factor: 21.873
Authors: Philipp Schuetz; Yannick Wirz; Ramon Sager; Mirjam Christ-Crain; Daiana Stolz; Michael Tamm; Lila Bouadma; Charles E Luyt; Michel Wolff; Jean Chastre; Florence Tubach; Kristina B Kristoffersen; Olaf Burkhardt; Tobias Welte; Stefan Schroeder; Vandack Nobre; Long Wei; Heiner C Bucher; Neera Bhatnagar; Djillali Annane; Konrad Reinhart; Angela Branche; Pierre Damas; Maarten Nijsten; Dylan W de Lange; Rodrigo O Deliberato; Stella Ss Lima; Vera Maravić-Stojković; Alessia Verduri; Bin Cao; Yahya Shehabi; Albertus Beishuizen; Jens-Ulrik S Jensen; Caspar Corti; Jos A Van Oers; Ann R Falsey; Evelien de Jong; Carolina F Oliveira; Bianca Beghe; Matthias Briel; Beat Mueller Journal: Cochrane Database Syst Rev Date: 2017-10-12
Authors: Ana I Cubas-Atienzar; Christopher T Williams; Abhilasha Karkey; Sabina Dongol; Manandhar Sulochana; Shrestha Rajendra; Glyn Hobbs; Katie Evans; Patrick Musicha; Nicholas Feasey; Luis E Cuevas; Emily R Adams; Thomas Edwards Journal: J Glob Antimicrob Resist Date: 2021-09-03 Impact factor: 4.035